It was suggested that CCL5, TYROBP, LILRB2, and MMP9 may play an essential role in the pathogenesis and development of ccRCC and may have potential clinical diagnostic and therapeutic value.[9] The survival rate of patients with low expression of TYROBP and LILRB2 genes was significantly higher than those with increased expression of LILRB2 and TYROBP genes. The gene discussed is LILRB2; the disease is nonpapillary renal cell carcinoma.